<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2021 16_5-6_202</article-id>
<article-id pub-id-type="doi">10.15836/ccar2021.202</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
</article-categories>
<title-group>
<article-title>Residual myocardial dyssynchrony after cardiac resynchronization therapy in patients with and without immediate echocardiographic optimization</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1542-2890</contrib-id><name><surname>Brestovac</surname><given-names>Marija</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1134-4856</contrib-id><name><surname>Glava&#x0161; Konja</surname><given-names>Blanka</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8446-6120</contrib-id><name><surname>Lovri&#x0107; Ben&#x010D;i&#x0107;</surname><given-names>Martina</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4721-3236</contrib-id><name><surname>Re&#x0161;kovi&#x0107; Luk&#x0161;i&#x0107;</surname><given-names>Vlatka</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1191-4831</contrib-id><name><surname>Ga&#x0161;parovi&#x0107;</surname><given-names>Kristina</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7349-6137</contrib-id><name><surname>Jurinjak</surname><given-names>Sandra Jak&#x0161;i&#x0107;</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3437-6407</contrib-id><name><surname>&#x0160;eparovi&#x0107; Han&#x017E;eva&#x010D;ki</surname><given-names>Jadranka</given-names></name></contrib>
<aff id="aff1"><institution content-type="dept">University of Zagreb School of Medicine</institution>, <institution>University Hospital Centre Zagreb</institution>, <addr-line>Zagreb</addr-line>, <country>Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Marija Brestovac, Klini&#x010D;ki bolni&#x010D;ki centar Zagreb, Ki&#x0161;pati&#x0107;eva 12, HR-10000 Zagreb, Croatia. / Phone: +385-99-7742-627 / E-mail: <email xlink:href="marija.brestovac@gmail.com">marija.brestovac@gmail.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>04</month><year>2021</year></pub-date>
<volume>16</volume>
<issue>5-6</issue>
<fpage>202</fpage>
<lpage>202</lpage>
<history>
<date date-type="received"><day>28</day><month>03</month><year>2021</year></date>
<date date-type="accepted"><day>02</day><month>04</month><year>2021</year></date>
</history>
<permissions>
<copyright-year>2021</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>cardiac resynchronization therapy</kwd><kwd>dyssynchrony</kwd><kwd>echocardiographic optimization</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction</bold>: Cardiac resynchronization therapy (CRT) is used in the treatment of severe symptomatic heart failure with LBBB. Such patients often have at least one echocardiographic sign of either one type of dyssynchrony, interventricular (VV), intraventricular or atrioventricular (AV), present. It is known that about 30% of patients are nonresponders to this type of treatment. One of the causes is residual dyssynchrony after CRT device implantation. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>, <xref ref-type="bibr" rid="r2"><italic>2</italic></xref>) The aim of this study was to determine whether there is a difference in the presence of any of the echocardiographic signs of dyssynchrony after 6 months of follow up using two different CRT optimization methods.</p>
<p><bold>Patients and Methods</bold>: We included 147 CRT patients in this study. Each patient underwent full echocardiographic study with assessing signs of dyssynchrony before and 6 months after CRT device implantation. Patients were divided into two groups according to the method of CRT optimization, echocardiographically (ECHO) or electrocardiographically (ECG) guided CRT optimization. In Both groups initially AV and VV delay optimization were set up according to QRS width. On top of this ECHO group was additionally echocardiographically optimized accordingly to echocardiographic signs of dyssynchrony, septal flash (SF) disappearance, A wave truncation and merged E and A waves (AVd) and interventricular mechanical delay (IVMD). After 6 months of follow up residual dyssynchrony was defined as presence of SF, AVd and/or IVMD &gt;40 ms.</p>
<p><bold>Results</bold>: In both groups, a significant reduction of echocardiographic signs of dyssynchrony was observed during the follow-up period. Comparison between the groups showed that residual SF and AVd were less frequent present in the ECHO group and reached statistically significance (p&lt;0.01 for SF and AVd) while IVMD reduction did not differ between groups (p=0.84) (<xref ref-type="table" rid="t1"><bold>Table 1</bold></xref>).</p>
<table-wrap id="t1" position="float">
<label>TABLE 1</label><caption><title>Comparison of echocardiographic signs of dyssynchrony before and 6 months after cardiac resynchronization therapy between the analyzed groups.</title>
</caption>
<table frame="hsides" rules="groups">
<col width="8.94%"/>
<col width="17%"/>
<col width="21.86%"/>
<col width="18.65%"/>
<col width="20.62%"/>
<col width="12.93%"/>
<thead>
<tr>
<th valign="middle" align="left" scope="col" style="border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></th>
<th valign="middle" colspan="2" align="center" scope="colgroup" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>ECG (N=70)</bold></th>
<th valign="middle" colspan="2" align="center" scope="colgroup" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>ECHO (N=77)</bold></th>
<th valign="middle" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-bottom: solid 0.25pt"></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left" style="border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"></td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">Before CRT</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">6 months after CRT</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">Before CRT</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">6 months after CRT</td>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-bottom: solid 0.25pt"></td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">SF</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">65 (92.8%)</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">26 (37.1%)</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">73 (94.8%)</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">14 (18.1%)</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>p&lt;0.01</bold></td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">AVd</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">49 (70%)</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">26 (37.1%)</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">52 (67.5%)</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">11 (14.2%)</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>p&lt;0.01</bold></td>
</tr>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">IVMD</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">53 (75.7%)</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">11 (15.7%)</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">55(71.4%)</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">8 (10.3%)</td>
<td valign="middle" align="center" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">p=0.84</td>
</tr>
<tr>
<td valign="middle" colspan="6" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.75pt" scope="col">SF - septal flash, AVd- atrioventricular dyssynchrony, IVMD- interventricular mechanical delay.</td>
</tr>
</tbody></table></table-wrap>
<p><bold>Conclusion</bold>: Echocardiographic optimization of CRT is associated with a greater reduction of residual SF and AV dyssynchrony compared to ECG optimization while no difference in the reduction of IVMD was observed between analyzed groups 6 months after CRT.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorcsan</surname><given-names>J</given-names><suffix>3rd</suffix></name><name><surname>Marek</surname><given-names>JJ</given-names></name><name><surname>Onishi</surname><given-names>T</given-names></name></person-group>. <article-title>The Contemporary Role of Echocardiography in Improving Patient Response to Cardiac Resynchronization Therapy.</article-title> <source>Curr Cardiovasc Imaging Rep</source>. <year>2012</year> December;<volume>5</volume>(<issue>6</issue>):<fpage>462</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1007/s12410-012-9172-2</pub-id><pub-id pub-id-type="pmid">24741393</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Everdingen</surname><given-names>WM</given-names></name><name><surname>Schipper</surname><given-names>JC</given-names></name><name><surname>van &#x2019;t Sant</surname><given-names>J</given-names></name><name><surname>Ramdat Misier</surname><given-names>K</given-names></name><name><surname>Meine</surname><given-names>M</given-names></name><name><surname>Cramer</surname><given-names>MJ</given-names></name></person-group>. <article-title>Echocardiography and cardiac resynchronisation therapy, friends or foes?</article-title> <source>Neth Heart J</source>. <year>2016</year> January;<volume>24</volume>(<issue>1</issue>):<fpage>25</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1007/s12471-015-0769-3</pub-id><pub-id pub-id-type="pmid">26645707</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
